ClinicalTrials.gov
ClinicalTrials.gov Menu

Qatar Cardiometabolic Registry

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03394313
Recruitment Status : Recruiting
First Posted : January 9, 2018
Last Update Posted : January 9, 2018
Sponsor:
Information provided by (Responsible Party):
Hamad Medical Corporation

Brief Summary:
Type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD) are closely related. T2DM risk equivalent for CVD and it remains the major cause of death in T2DM. Thus, patients with T2DM and CVD disease are at very high-risk of CVD-related mortality. Therefore, more aggressive metabolic and hemodynamic control is required in such patients to improve the prognosis. We recently initiated a cardio-metabolic clinical service at the Heart Hospital, where T2DM patients with existing CVD are simultaneously examined by Cardiologist and Diabetologist for optimal metabolic and hemodynamic control. We would like to start a clinical registry for all patients who attend this clinical service to collect import clinical data about this population. This registry will serve an important source for future clinical research in the field.

Condition or disease
Diabetes Mellitus Cardiovascular Diseases

  Show Detailed Description

Study Type : Observational
Estimated Enrollment : 50000 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Qatar Cardiometabolic Registry
Actual Study Start Date : September 15, 2017
Estimated Primary Completion Date : December 31, 2027
Estimated Study Completion Date : December 31, 2027



Primary Outcome Measures :
  1. Mortality [ Time Frame: Ten years (15/09/2017 to 31/12/2027) ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Sampling Method:   Non-Probability Sample
Study Population
Patients with type 2 diabetes mellitus and cardiovascular disease
Criteria

Inclusion Criteria:

  • Patients with type 2 diabetes mellitus
  • Newly diagnosed heart disease, such as ischemic heart disease, heart failure.

Exclusion Criteria:

  • Patients who do not have type 2 diabetes mellitus
  • Preexisting heart disease

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03394313


Contacts
Contact: Jassim Al-Suwaidi, MD 55823041 jalsuwaidi@hamad.qa
Contact: Rajvir Singh, Ph.D rsingh@hamad.qa

Locations
Qatar
Hamad Medical Coorporation Recruiting
Doha, Qatar, 3050
Contact: Jassim Al-Suwaidi, MD    55823041      
Sponsors and Collaborators
Hamad Medical Corporation
Investigators
Principal Investigator: Jassim Al-Suwaidi, MD Hamad Medical Coorporation

Publications:
Responsible Party: Hamad Medical Corporation
ClinicalTrials.gov Identifier: NCT03394313     History of Changes
Other Study ID Numbers: MRC-01-17-003
First Posted: January 9, 2018    Key Record Dates
Last Update Posted: January 9, 2018
Last Verified: December 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Hamad Medical Corporation:
Registry

Additional relevant MeSH terms:
Diabetes Mellitus
Cardiovascular Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases